Advantages of Working Together through HBD Activities: JP Regulators’ View - Shin Iwamoto, PhD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - Session V: Evaluating Peripheral Arterial Calcification in Japan and in USA?

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Advantages of Working Together through HBD Activities: JP Regulators’ View presented by Shin Iwamoto, PhD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Clinical Trial Investigators
  • Medical Device Professionals

Session Name: Session V: Evaluating Peripheral Arterial Calcification in Japan and in USA?

Track: Technology & Innovation

Learning Objectives

  • Updates on regulatory harmonisation and clinical trial design in the US & Japan

Other Components in this Moment

Overview
Proposed Evaluation Score for Peripheral Arterial Calcification from U.S. Academia - Michael R. Jaff, DO
Current JP Situation of Evaluation for Peripheral Arterial Calcification – Japan Academia’s View - Hiroyoshi Yokoi, MD
Current US Activities for Grading Peripheral Arterial Calcification – Industry View - Megan M. Brandt
Advantages of Working Together through HBD Activities: JP Regulators’ View - Shin Iwamoto, PhD
Advantages of Working Together through HBD Activities: US Regulators’ View - K. J. Cavanaugh, PhD
Closing Remarks - Hiroyoshi Yokoi, MD
Loading Simple Education